UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): February 3, 2011

 

 

Codexis, Inc.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   001-34705   71-0872999
(State or other Jurisdiction of   (Commission   (IRS Employer
Incorporation or Organization)   File Number)   Identification No.)

 

Codexis, Inc.

200 Penobscot Drive

Redwood City, CA

   94063
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: 650-421-8100

 

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 2.02. Results of Operations and Financial Condition

On February 3, 2011, Codexis, Inc. announced its financial results for the fourth quarter and year ended December 31, 2010. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such a filing.

 

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

The following exhibit relating to Item 2.02 shall be deemed to be furnished and not filed:

 

99.1 Press Release dated February 3, 2011, entitled “Codexis Grows Annual Revenue 29% to $107 million; 77% Increase in Pharmaceutical Product Sales”

 

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CODEXIS, INC.
Date: February 3, 2011   By:  

/s/    ROBERT LAWSON        

    Robert Lawson
    Chief Financial Officer

 

3

EXHIBIT INDEX

 

Exhibit
No.

   

Description

99.1    Press Release dated February 3, 2011, entitled “Codexis Grows Annual Revenue 29% to $107 million; 77% Increase in Pharmaceutical Product Sales”

 

4